Nexien BioPharma has acquired Princeton, New Jersey based CRx Bio Holdings LLC. CRx is engaged in the research and development of advanced cannabinoid therapeutic formulations with the objective of enhancing the bioavailability, pharmacokinetics, and pharmacodynamics of cannabinoids. Nexien and CRx both share a common vision of developing cannabinoid based and FDA approved therapeutics to treat…